Allergy Therapeutics Stock Quote AGY - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
UK
LSE
Allergy Therapeutics Plc (AGY) Quote

Allergy Therapeutics Plc (AGY)

5.20

0.00

(0.00%)

Closed December 03 11:30AM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

5.20

Bid

5.00

Ask

5.50

Volume

1,211,588

5.10 Day's Range 5.26

1.88 52 Week Range 6.05

Market Cap

Previous Close

5.20

Open

5.25

Last Trade

Last Trade Time

Financial Volume

63,166p

VWAP

5.2135

Average Volume (3m)

367,781

Shares Outstanding

4,766,439,938

Dividend Yield

-

PE Ratio

-6.25

Earnings Per Share (EPS)

-0.01

Revenue

55.2M

Net Profit

-40.22M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.allergytherapeutics.com

Headquarters

West Sussex, Gbr

Founded

-

Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 5.20p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 1.88p to 6.05p.

Allergy Therapeutics currently has 4,766,439,938 shares outstanding. The market capitalization of Allergy Therapeutics is £247.85 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -6.25.

IN BRIEF: Allergy Therapeutics treats first patient in allergy trial

ics PLC - Sussex, England-based biotechnology company - Treats its first patient in the third phase of its paediatric ...

Allergy Therapeutics PLC First Patient Dosed in G308 Paediatric Trial

Allergy Therapeutics PLC 27 November 2024 Allergy Therapeutics plc ("Allergy Therapeutics", "ATL" or the "Group") Allergy Therapeutics announces first patient treated in G308 Phase III...

Allergy Therapeutics PLC Submission of MAA for Grass MATA MPL

Allergy Therapeutics PLC 25 November 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Allergy Therapeutics Submits Marketing Authorisation Application for Grass MATA...

Allergy Therapeutics PLC Notice of 2024 Annual General Meeting

Allergy Therapeutics PLC 21 November 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") Notice of 2024 Annual General Meeting 21 November 2024 - Allergy...

Allergy Therapeutics annual loss narrows thanks to reduced expenses

Allergy Therapeutics PLC on Wednesday said it narrowed its loss during its most recent financial year despite a decli ...

Allergy Therapeutics PLC Audited Preliminary Results 2024

Allergy Therapeutics PLC 06 November 2024 Allergy Therapeutics PLC ("Allergy Therapeutics" or the "Group") Audited Preliminary Results for the Year ended 30 June 2024 - ...

Allergy Therapeutics enrols candidates for grass pollen allergy trial

Allergy Therapeutics PLC on Monday revealed that the first candidates have been enrolled in its phase III paediatric ...

Allergy Therapeutics PLC Commencement of Phase III Paediatric Trial

Allergy Therapeutics PLC 21 October 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Allergy Therapeutics commences Phase III paediatric trial for Grass MATA MPL ...

Allergy Therapeutics shares surge as enters into secured loan facility

Allergy Therapeutics PLC shares rallied on Wednesday after it announced a funding update with an alternative asset ma ...

Allergy Therapeutics PLC Update on funding

Allergy Therapeutics PLC 16 October 2024 Allergy Therapeutics plc ("Allergy Therapeutics", the "Group" or "Company") Update on funding 16 October 2024 Allergy Therapeutics plc (AIM:...

IN BRIEF: Allergy Therapeutics treats first patient in allergy trial

ics PLC - Sussex, England-based biotechnology company - Treats its first patient in the third phase of its paediatric ...

Allergy Therapeutics PLC First Patient Dosed in G308 Paediatric Trial

Allergy Therapeutics PLC 27 November 2024 Allergy Therapeutics plc ("Allergy Therapeutics", "ATL" or the "Group") Allergy Therapeutics announces first patient treated in G308 Phase III...

Allergy Therapeutics PLC Submission of MAA for Grass MATA MPL

Allergy Therapeutics PLC 25 November 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Allergy Therapeutics Submits Marketing Authorisation Application for Grass MATA...

Allergy Therapeutics PLC Notice of 2024 Annual General Meeting

Allergy Therapeutics PLC 21 November 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") Notice of 2024 Annual General Meeting 21 November 2024 - Allergy...

Allergy Therapeutics annual loss narrows thanks to reduced expenses

Allergy Therapeutics PLC on Wednesday said it narrowed its loss during its most recent financial year despite a decli ...

Allergy Therapeutics PLC Audited Preliminary Results 2024

Allergy Therapeutics PLC 06 November 2024 Allergy Therapeutics PLC ("Allergy Therapeutics" or the "Group") Audited Preliminary Results for the Year ended 30 June 2024 - ...

Allergy Therapeutics enrols candidates for grass pollen allergy trial

Allergy Therapeutics PLC on Monday revealed that the first candidates have been enrolled in its phase III paediatric ...

Allergy Therapeutics PLC Commencement of Phase III Paediatric Trial

Allergy Therapeutics PLC 21 October 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Allergy Therapeutics commences Phase III paediatric trial for Grass MATA MPL ...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.05	-0.952380952381	5.25	5.55	5.06	571130	5.25784236	DE
4	0.2	4	5	5.62	5	410703	5.35709138	DE
12	1.15	28.3950617284	4.05	5.62	3.95	367781	4.97726713	DE
26	1.15	28.3950617284	4.05	6.05	3.88	492673	5.13471844	DE
52	3.25	166.666666667	1.95	6.05	1.88	665771	3.58102859	DE
156	-30.3	-85.3521126761	35.5	35.5	0.85	496008	4.29074094	DE
260	-6.3	-54.7826086957	11.5	40	0.85	433344	9.17367593	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SCGLSealand Capital Galaxy Limited	0.54p (80.00%)	36.26M
OBDOxford Biodynamics Plc	2.11p (55.15%)	8.3M
MIRIMirriad Advertising Plc	0.18p (33.33%)	23.04M
CLCOCloudcoco Group Plc	0.26p (30.00%)	3.42M
IESInvinity Energy Systems Plc	15.00p (27.66%)	4.57M
ZNTZentra Group Plc	3.50p (-36.36%)	221.85k
UOGUnited Oil & Gas Plc	0.125p (-34.21%)	123.45M
SYSSysgroup Plc	21.50p (-24.56%)	788.98k
ADAAdams Plc	3.50p (-22.22%)	25k
DSMDowning Strategic Micro-cap Investment Trust Plc	3.70p (-21.28%)	22.32k
ORCPOracle Power Plc	0.0525p (-7.89%)	3.65B
NTVONativo Resources Plc	0.0023p (-8.00%)	1.51B
SYMESupply@me Capital Plc	0.0031p (-10.14%)	1.11B
KEFIKefi Gold And Copper Plc	0.524p (-19.63%)	567.23M
ENETEthernity Networks Ltd	0.1425p (18.75%)	551.92M

pos_stock_hoarder

pos_stock_hoarder 1 minute ago

I don't think he'll ever get it.

https://assets.amuniversal.com/62a6cc908601013d7d8f005056a9545d

Zorax

Zorax 2 minutes ago

There's nothing warm or inviting about mello's face. Cold as a dead fish.

linkvest

linkvest 2 minutes ago

As the doors would say.....

getmoreshares

getmoreshares 2 minutes ago

FYI-- SS was updated yesterday: Held at DTC 3,549,178,515 12/02/2024

Rainer

Rainer 2 minutes ago

beurstips

beurstips 2 minutes ago

+50%...my best stock this year..almost x3 ....i hope some bought also when i said to diversify in this sector...strange that insiders were selling early in year...thanks Credo for the early X - mas present...next year spectra7 to have a x3 - x5 year?

L8TR

L8TR 2 minutes ago

GWAV Monster 🔥

wadegarret

wadegarret 2 minutes ago

SMCI selling for 11 PE going forward

The main reason I'm getting more interested is, the stock is still down 66% from the highs, and only because of concerns over their prior auditor quiting. Now their in house auditors say nothing they can find, and BDO gearning up to give their

bas2020

bas2020 2 minutes ago

Believe me, there are plenty I know who are buying dips at this point. Tell your handlers 'thanks' for us!

L8TR

L8TR 3 minutes ago

GWAV Monster🔥

flipper44

flipper44 3 minutes ago

Ms Labonte

Ms Labonte 3 minutes ago

Fill em bid$$ bitche$$ Drop your pant$$$

getmoreshares

getmoreshares 3 minutes ago

at least get us off the EXPERT "defunct" list https://www.otcmarkets.com/stock/BCAP/overview

LowFloatLopes

LowFloatLopes 4 minutes ago

Added today ..I think she blows soon ;)

GRegoty

GRegoty 4 minutes ago

Wait, I'm sure I can find a pic! Lol

johnydollar

johnydollar 4 minutes ago

Are you gonna buy millions of shares like us........

And we can all be good amigos......

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹

pos_stock_hoarder

pos_stock_hoarder 4 minutes ago

Some good news!

Investors3

Investors3 5 minutes ago

Gene Munster sees long-term upside for Apple stock
Monday, December 2, 2024 1:01 pm
No Comments

Last month, Deepwater Asset Management’s Gene Munster said in an interview on CNBC that the impact of Apple Intelligence on Apple’s earnings won’t be seen until the next “few

TrendTrade2016

TrendTrade2016 5 minutes ago

HOW MUCH ARE YOUR STOCKS UP MAGGOT

Humbert

Humbert 5 minutes ago

I'm usually correct.

GetSeriousOK

GetSeriousOK 5 minutes ago

The MundiPharma suit is still on the table. Do you really want them to borrow money to sue MundiPharma in southeast Asia? Even if, by some slim chance, they WON, they'd never collect the money because who would make MundiPharma pay those Yankees? And whether they wein or lose they;'d have to pay th

janetcanada

janetcanada 5 minutes ago

👀*** GRST- Intelligent Peoples are Far From Being Obtuse!.....

pos_stock_hoarder

pos_stock_hoarder 5 minutes ago

I'd be happy to waive her sentence and deport her the hell back to where ever! I guess that will have to be AFTER Jan. 20!!!

Allergy Therapeutics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions